These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3584724

  • 1. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC, McLaran CJ, Wood DL, Osborn MJ, Gersh BJ, Holmes DR.
    J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A.
    Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study.
    Huycke EC, Sung RJ, Dias VC, Milstein S, Hariman RJ, Platia EV.
    J Am Coll Cardiol; 1989 Mar 01; 13(3):538-44. PubMed ID: 2918157
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous propafenone for termination of reentrant supraventricular tachycardia. A placebo-controlled, randomized, double-blind, crossover study.
    Shen EN, Keung E, Huycke E, Dohrmann ML, Nguyen N, Morady F, Sung RJ.
    Ann Intern Med; 1986 Nov 01; 105(5):655-61. PubMed ID: 3767146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
    Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F.
    G Ital Cardiol; 1986 Apr 01; 16(4):336-43. PubMed ID: 3743937
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS.
    Rev Port Cardiol; 1994 Mar 01; 13(3):197-202, 191. PubMed ID: 8049086
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome.
    Dubuc M, Kus T, Campa MA, Lambert C, Rosengarten M, Shenasa M.
    Am Heart J; 1989 Feb 01; 117(2):370-6. PubMed ID: 2644795
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study.
    Chen X, Borggrefe M, Martinez-Rubio A, Hief C, Haverkamp W, Hindricks G, Breithardt G.
    J Cardiovasc Pharmacol; 1994 Oct 01; 24(4):664-9. PubMed ID: 7528850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The response of paroxysmal supraventricular tachycardia to overdrive atrial and ventricular pacing: can it help determine the tachycardia mechanism?
    Kadish AH, Morady F.
    J Cardiovasc Electrophysiol; 1993 Jun 01; 4(3):239-52. PubMed ID: 8269296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.